Range
73.35 - 75.29
Vol / Avg.
481.4K/511.5K
Div / Yield
-
52 Wk
22.36 - 93.94
Mkt Cap
9.1B
Payout Ratio
-
Open
74.25
P/E
125
EPS
-0.58
Shares
121.2M
Outstanding
121.2M
Total Float
-
load more
Sector: Health Care.Industry: Biotechnology
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-06
REV
Q1 2021Est.ActualSurprise
EPS-0.580
REV7.923M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
DNLIDenali Therapeutics1.06%9.1B

Denali Therapeutics Frequently Asked Questions

Q

How do I buy Denali Therapeutics (DNLI) stock?

A

You can purchase shares of Denali Therapeutics (NASDAQ: DNLI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Denali Therapeutics's (DNLI) competitors?

Q

What is the target price for Denali Therapeutics (DNLI) stock?

A

The latest price target for Denali Therapeutics (NASDAQ: DNLI) was reported by UBS on May 18, 2021. The analyst firm set a price target for 70.00 expecting DNLI to fall to within 12 months (a possible -6.67% downside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Denali Therapeutics (DNLI)?

A

The stock price for Denali Therapeutics (NASDAQ: DNLI) is $75 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Denali Therapeutics (DNLI) pay a dividend?

A

There are no upcoming dividends for Denali Therapeutics.

Q

When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?

A
Denali Therapeutics’s Q2 earnings are confirmed for after-market on August 6, 2021.
Q

Is Denali Therapeutics (DNLI) going to split?

A

There is no upcoming split for Denali Therapeutics.

Q

What sector and industry does Denali Therapeutics (DNLI) operate in?

A

Denali Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.